Cellectis (CLLS) Operating Leases (2018 - 2026)
Cellectis (CLLS) recorded quarterly Operating Leases of $25.9 million in Q1 2026, down 6.41% quarter-over-quarter from $27.7 million in Q4 2025, and down 21.7% on a YoY basis from $33.1 million in Q1 2025.
Cellectis (CLLS) Operating Leases (2018 - 2026) Analysis & Trends
Cellectis' Operating Leases history runs 9 years deep, the most recent figure standing at $25.9 million for Q1 2026.
- In Q1 2026, Operating Leases fell 21.7% year-over-year to $25.9 million; the TTM figure through Mar 2026 stood at $25.9 million (down 21.7% YoY), while the FY2025 annual figure was $27.7 million, down 19.04% from the prior year.
- Operating Leases was $25.9 million for Q1 2026 at Cellectis, down from $27.7 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $69.7 million in Q1 2022 to a low of $25.9 million in Q1 2026.
- Historically, Operating Leases has averaged $42.9 million across 5 years, with a median of $40.6 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Operating Leases retreated 4.99% in 2022, then slumped 31.1% in 2023.
- A 5-year view of Operating Leases shows it stood at $49.4 million in 2022, then declined by 12.99% to $42.9 million in 2023, then slipped by 20.26% to $34.2 million in 2024, then slipped by 19.04% to $27.7 million in 2025, then retreated by 6.41% to $25.9 million in 2026.
- The last three Operating Leases figures came in at $25.9 million (Q1 2026), $27.7 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.95 Mn |
| Dec 31, 2025 | 27.73 Mn |
| Sep 30, 2025 | 29.25 Mn |
| Jun 30, 2025 | 32.26 Mn |
| Mar 31, 2025 | 33.14 Mn |
| Dec 31, 2024 | 34.25 Mn |
| Sep 30, 2024 | 36.68 Mn |
| Jun 30, 2024 | 38.36 Mn |
| Mar 31, 2024 | 40.59 Mn |
| Dec 31, 2023 | 42.95 Mn |
| Sep 30, 2023 | 43.82 Mn |
| Jun 30, 2023 | 46.16 Mn |
| Mar 31, 2023 | 48.29 Mn |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 63.59 Mn |
| Jun 30, 2022 | 66.59 Mn |
| Mar 31, 2022 | 69.74 Mn |
| Dec 31, 2021 | 71.53 Mn |
| Sep 30, 2021 | 73.73 Mn |
| Jun 30, 2021 | 75.76 Mn |